Fromkin Andrew J.
SEC CIK 1341896 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| IMVT | Immunovant, Inc. | Dir | 296.3K | $43.5K | $8.60M | 12 | 2021-08-10 | 2026-05-28 |
Most active insiders at IMVT, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Roivant Sciences Ltd. | Dir, 10% | $350.00M | — |
| 2 | Fromkin Andrew J. | Dir | — | $7.96M |
| 3 | Stout Jay S | CTO | — | $2.27M |
| 4 | Gloria Melanie | COO | — | $1.60M |
| 5 | Girao Tiago | CFO | — | $1.41M |
| 6 | Van Tuyl Christopher | CLO | — | $1.31M |
| 7 | Venker Eric | CEO, Dir | — | $461.8K |
| 8 | Pande Atul | Dir | — | $424.6K |
| 9 | Hughes Douglas J. | Dir | — | $348.7K |
| 10 | Geffner Michael | Chief Medical Off | — | $70.1K |
Transactions 12
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2026-05-29 16:04 | 2026-05-28 | IMVT | Immunovant, Inc. | Fromkin Andrew J. | Dir | M - OptEx | $8.22 | +196.6K | 296.3K | +197% | +$1.62M |
| DM | 2026-05-29 16:04 | 2026-05-28 | IMVT | Immunovant, Inc. | Fromkin Andrew J. | Dir | S - Sale+OE | $33.51 | -222.0K | 74.4K | -75% | -$7.44M |
| D | 2026-04-09 16:28 | 2026-04-07 | IMVT | Immunovant, Inc. | Fromkin Andrew J. | Dir | A - Grant | $0.00 | +13.9K | 99.7K | +16% | $0 |
| M | 2025-12-03 | 2025-12-01 | IMVT | Immunovant, Inc. | Fromkin Andrew J. | Dir | S - Sale | $23.25 | -22.2K | 85.9K | -21% | -$517.2K |
| D | 2025-04-03 | 2025-04-01 | IMVT | Immunovant, Inc. | Fromkin Andrew J. | Dir | A - Grant | $0.00 | +16.2K | 108.1K | +18% | $0 |
| M | 2025-03-11 | 2025-03-07 | IMVT | Immunovant, Inc. | Fromkin Andrew J. | Dir | S - Sale | $19.60 | -8,000 | 91.9K | -8% | -$156.8K |
| D | 2024-04-04 | 2024-04-02 | IMVT | Immunovant, Inc. | Fromkin Andrew J. | Dir | A - Grant | $0.00 | +11.3K | 99.9K | +13% | $0 |
| M | 2023-12-05 | 2023-12-01 | IMVT | Immunovant, Inc. | Fromkin Andrew J. | Dir | S - Sale | $39.73 | -12.3K | 93.4K | -12% | -$490.7K |
| D | 2023-04-14 | 2023-04-12 | IMVT | Immunovant, Inc. | Fromkin Andrew J. | Dir | A - Grant | $0.00 | +12.5K | 101.0K | +14% | $0 |
| D | 2022-08-19 | 2022-08-17 | IMVT | Immunovant, Inc. | Fromkin Andrew J. | Dir | A - Grant | $0.00 | +21.1K | 88.5K | +31% | $0 |
| D | 2022-01-12 | 2022-01-10 | IMVT | Immunovant, Inc. | Fromkin Andrew J. | Dir | A - Grant | $0.00 | +21.7K | 67.4K | +48% | $0 |
| 2021-08-11 | 2021-08-10 | IMVT | Immunovant, Inc. | Fromkin Andrew J. | Dir | P - Purchase | $7.90 | +5,500 | 45.7K | +14% | +$43.5K |
Purchase Sale Sale after option exercise All abbreviations